Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects. - Vigneron SF; Ohno S; Braz J; Kim JY; Kweon OS; Webb C; Billesbølle CB; Srinivasan K; Bhardwaj K; Irwin JJ; Manglik A; Basbaum AI; et al. (ACS central science, 2025)